[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zagrebelsky et al., 2020 - Google Patents

BDNF signaling during the lifetime of dendritic spines

Zagrebelsky et al., 2020

View HTML
Document ID
10938930768742576150
Author
Zagrebelsky M
Tacke C
Korte M
Publication year
Publication venue
Cell and Tissue Research

External Links

Snippet

Dendritic spines are tiny membrane specialization forming the postsynaptic part of most excitatory synapses. They have been suggested to play a crucial role in regulating synaptic transmission during development and in adult learning processes. Changes in their number …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Zagrebelsky et al. BDNF signaling during the lifetime of dendritic spines
Kuczewski et al. Activity-dependent dendritic release of BDNF and biological consequences
Sheng et al. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration
Nave et al. Myelination of the nervous system: mechanisms and functions
Lu et al. BDNF and synaptic plasticity, cognitive function, and dysfunction
Owens et al. Is there more to GABA than synaptic inhibition?
Theis et al. Connexin-based intercellular communication and astrocyte heterogeneity
Carvalho et al. Role of the brain‐derived neurotrophic factor at glutamatergic synapses
Kolarow et al. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium–calmodulin kinase II signaling and proceeds via delayed fusion pore opening
Ho et al. Tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?
Madathil et al. IGF-1/IGF-R signaling in traumatic brain injury: impact on cell survival, neurogenesis, and behavioral outcome
Sampathkumar et al. Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons
Mohebiany et al. New insights into the roles of the contactin cell adhesion molecules in neural development
Twiss et al. Pathophysiological mechanisms for actions of the neurotrophins
Li et al. Satb2 ablation impairs hippocampus-based long-term spatial memory and short-term working memory and immediate early genes (IEGs)-mediated hippocampal synaptic plasticity
Zhou et al. Adenosine A1 receptors play an important protective role against cognitive impairment and long-term potentiation inhibition in a pentylenetetrazol mouse model of epilepsy
Hammelmann et al. Abolishing cAMP sensitivity in HCN2 pacemaker channels induces generalized seizures
Puntman et al. Munc18-1 is essential for neuropeptide secretion in neurons
Okabe Fluorescence imaging of synapse dynamics in normal circuit maturation and in developmental disorders
Sampedro-Castañeda et al. Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2. 3, altering inactivation kinetics and neuronal excitability
Ma et al. Disruption of MET receptor tyrosine kinase, an autism risk factor, impairs developmental synaptic plasticity in the Hippocampus
Miller et al. Pregnancy-associated plasma protein-aa regulates photoreceptor synaptic development to mediate visually guided behavior
Tacke et al. Actions of the TrkB agonist antibody ZEB85 in regulating the architecture and synaptic plasticity in hippocampal neurons
WO2021100685A1 (en) Treatment or prevention of psychiatric disease based on kif3 motor, and drug screening
Madathil et al. IGF-1/IGF-R signaling in traumatic brain injury